Загрузка...
A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
Glioblastoma is the most malignant tumor and has high mortality rate. The methylated prompter of MGMT results in chemotherapy sensitivity for these patients. However, there are still other factors that affected the prognosis for the glioblastoma patients with similar MGMT methylation status. We deve...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342529/ https://ncbi.nlm.nih.gov/pubmed/27588397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11726 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|